Notice Information
Notice Title
GSTT - Provision of Aseptic Managed Service
Notice Description
The Trust has a requirement for controlled environments for the preparation of high-risk injectable medicines into ready-to-administer (RtA) formats for patients. Aseptic facilities are also required for the manufacture of Advanced Therapy medicines including gene, cell and viral therapies, and a growing number of Investigational Medicinal Products used in clinical trials.
Lot Information
Lot 1
The proposed aseptic service will have the capability and capacity to deliver timely and reliable medicines for chemotherapy, Parenteral Nutrition, CIVAS antibiotics, clinical trials and also support growing demand for advanced gene therapies. Quality and patient safety considerations are key with drug compounding including aseptically prepared, hazardous chemotherapy drugs and investigational medicinal. Innovation driven by Research and Development is key to support GSTT's ambitions in being at the forefront of aseptic services. The new service will meet both today's and future needs of our patients, supplying tailored made drugs, to the right patient, at the right time, at the right quality, safely and also support GSTT's track record of being a leader in implementing new innovative treatments.
Partners will work with GSTT to design an aseptic service which considers both onsite and offsite aseptic units to meet patient and clinical needs. The new model of delivery will include investment in new sterile aseptic units, state of the art robotic equipment, IT production management systems, drug compounds, support with staffing and training and other supporting services required to deliver quality medicines. A long-term partnership is envisaged of 10 to 15 years to establish the capacity to meet the growing demands for aseptic drugs for patients. Commercial aseptic sales opportunities will be explored to maximise the investment and deliver wider benefit to the NHS. Additional information: GSTT Aseptic Services is one of two divisions of Pharmacy Technical Services, with the other division being the Pharmacy Specials Manufacturing Unit which is out of scope of this PIN.
Pharmacy Technical Services is part of the Pharmacy and Medicines Optimisation Division which is also responsible for outpatient pharmacy services. The Pharmacy and Medicines Optimisation Division forms part of GSTTs Integrated and Specialised Medicine Clinical Group.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-03faf2
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/026521-2023
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
85 - Health and social work services
-
- CPV Codes
33000000 - Medical equipments, pharmaceuticals and personal care products
33600000 - Pharmaceutical products
33690000 - Various medicinal products
33692000 - Medical solutions
33692100 - Infusion solutions
33692200 - Parenteral nutrition products
33692210 - Parenteral feeding solutions
33692300 - Enteral feeds
33692500 - Injectable solutions
33692510 - Intravenous fluids
85149000 - Pharmacy services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 7 Sep 20232 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 6 Sep 2023Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planned
- Lots Status
- Planned
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- GUY'S AND ST THOMAS' NHS FOUNDATION TRUST
- Contact Name
- Kemi Ore
- Contact Email
- kemi.ore@gstt.nhs.uk
- Contact Phone
- +44 207887188
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 9RT
- Post Town
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI44 Lewisham and Southwark
- Delivery Location
- TLI London
-
- Local Authority
- Southwark
- Electoral Ward
- London Bridge & West Bermondsey
- Westminster Constituency
- Bermondsey and Old Southwark
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-03faf2-2023-09-07T16:53:35+01:00",
"date": "2023-09-07T16:53:35+01:00",
"ocid": "ocds-h6vhtk-03faf2",
"description": "Suppliers are asked to complete a Questionnaire available to download from the Tender Box to respond to this PIN Notice with a deadline for responses of 12th October 2023",
"initiationType": "tender",
"tender": {
"id": "ST23-P076",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "GSTT - Provision of Aseptic Managed Service",
"status": "planned",
"classification": {
"scheme": "CPV",
"id": "85149000",
"description": "Pharmacy services"
},
"mainProcurementCategory": "services",
"description": "The Trust has a requirement for controlled environments for the preparation of high-risk injectable medicines into ready-to-administer (RtA) formats for patients. Aseptic facilities are also required for the manufacture of Advanced Therapy medicines including gene, cell and viral therapies, and a growing number of Investigational Medicinal Products used in clinical trials.",
"lots": [
{
"id": "1",
"description": "The proposed aseptic service will have the capability and capacity to deliver timely and reliable medicines for chemotherapy, Parenteral Nutrition, CIVAS antibiotics, clinical trials and also support growing demand for advanced gene therapies. Quality and patient safety considerations are key with drug compounding including aseptically prepared, hazardous chemotherapy drugs and investigational medicinal. Innovation driven by Research and Development is key to support GSTT's ambitions in being at the forefront of aseptic services. The new service will meet both today's and future needs of our patients, supplying tailored made drugs, to the right patient, at the right time, at the right quality, safely and also support GSTT's track record of being a leader in implementing new innovative treatments.<br/><br/>Partners will work with GSTT to design an aseptic service which considers both onsite and offsite aseptic units to meet patient and clinical needs. The new model of delivery will include investment in new sterile aseptic units, state of the art robotic equipment, IT production management systems, drug compounds, support with staffing and training and other supporting services required to deliver quality medicines. A long-term partnership is envisaged of 10 to 15 years to establish the capacity to meet the growing demands for aseptic drugs for patients. Commercial aseptic sales opportunities will be explored to maximise the investment and deliver wider benefit to the NHS. Additional information: GSTT Aseptic Services is one of two divisions of Pharmacy Technical Services, with the other division being the Pharmacy Specials Manufacturing Unit which is out of scope of this PIN. <br/>Pharmacy Technical Services is part of the Pharmacy and Medicines Optimisation Division which is also responsible for outpatient pharmacy services. The Pharmacy and Medicines Optimisation Division forms part of GSTTs Integrated and Specialised Medicine Clinical Group.",
"status": "planned"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
{
"scheme": "CPV",
"id": "33000000",
"description": "Medical equipments, pharmaceuticals and personal care products"
},
{
"scheme": "CPV",
"id": "33690000",
"description": "Various medicinal products"
},
{
"scheme": "CPV",
"id": "33692000",
"description": "Medical solutions"
},
{
"scheme": "CPV",
"id": "33692100",
"description": "Infusion solutions"
},
{
"scheme": "CPV",
"id": "33692210",
"description": "Parenteral feeding solutions"
},
{
"scheme": "CPV",
"id": "33692200",
"description": "Parenteral nutrition products"
},
{
"scheme": "CPV",
"id": "33692510",
"description": "Intravenous fluids"
},
{
"scheme": "CPV",
"id": "33692500",
"description": "Injectable solutions"
},
{
"scheme": "CPV",
"id": "33692300",
"description": "Enteral feeds"
}
],
"deliveryAddresses": [
{
"region": "UKI"
}
],
"relatedLot": "1"
}
],
"communication": {
"futureNoticeDate": "2023-09-07T00:00:00+01:00",
"atypicalToolUrl": "https://health-family.force.com/s/Welcome"
}
},
"parties": [
{
"id": "GB-FTS-9768",
"name": "Guy's and St Thomas' NHS Foundation Trust",
"identifier": {
"legalName": "Guy's and St Thomas' NHS Foundation Trust"
},
"address": {
"streetAddress": "Great Maze Pond",
"locality": "London",
"region": "UKI44",
"postalCode": "SE1 9RT",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Kemi Ore",
"telephone": "+44 207887188",
"email": "kemi.ore@gstt.nhs.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.guysandstthomas.nhs.uk",
"buyerProfile": "https://www.guysandstthomas.nhs.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
}
],
"buyer": {
"id": "GB-FTS-9768",
"name": "Guy's and St Thomas' NHS Foundation Trust"
},
"language": "en"
}